Pharmacology@Edinburgh

Edinburgh Pharmacology Symposium 2017

The 2nd Edinburgh Pharmacology Symposium and networking event will be held on the 5th May 2017 in the Hugh Robson Lecture Theatre.

Programme

8.50-9.00am - Opening Address

 

9.00-9.40am - Plenary Lecture:

The Pharmacology of AMPK: Evolution and Natural Selection

Professor D. Grahame Hardie FRS, FRSE, FMedSci,

School of Life Sciences, University of Dundee, UK. 

 

9.50-11.15am 

Session 1: Target Identification in Neuro-developmental and Neuro-degenerative Diseases

Chair: Professor David Wyllie

 

Functional assessment of gene correction of C9ORF72 repeat expansion

Dr Matthew Livesey, Centre for Integrative Physiology, University of Edinburgh

 

NMDA receptors, de novo mutations and neurodevelopmental disorders

Dr Katie Marwick, Centre for Integrative Physiology, University of Edinburgh

 

Potential therapeutic approaches in the treatment of Rett Syndrome

Dr Stuart Cobb, Institute of Neuroscience and Psychology, University of Glasgow 

 

11.15-11.45 - COFFEE

 

11.45-13.00

Session 2 - From Molecule to Man: A Healthy Heart And All That

Chair: Dr Gillian Gray

 

miRNA based therapy in vascular biology: what works and what doesn't

Dr Andrea Caporali, Chancellors Fellow,

BHF Centre for Cardiovascular Science, QMRI, Edinburgh Medical School. 

 

The eye as a window to the kidney

Dr Neeraj Dhaun,

Intermediate Clinical Fellow, BHF Centre for Cardiovascular Science, QMRI, Edinburgh Medical School. 

 

Title TBC

Dr Isla Mackenzie,

Medicines Monitoring Unit (MEMO) and Hypertension Research Centre (HRC), University of Dundee and Ninewells Hospital.

 

13.00-14.30 - LUNCH

 

14.30-15.45

Session 3 - Academic Drug Discovery: breaking down barriers

Chair: Dr Scott Webster

 

Innovating in Cancer Therapy and Drug Discovery

Dr Asier Uncit-Broceta,

The Innovative Therapeutics Lab, Cancer Research UK Edinburgh Centre, University of Edinburgh 

 

Drug discovery for neglected diseases

Dr Ian Gilbert FRSC,

Head of the Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee. 

 

Kynurenine Monooxygenase inhibitors for the prevention of multiple organ failure in Severe Acute Pancreatitis - An Industrial- Academic partnership

Dr Jon Hutchinson,

GSK, Stevenage, UK. 

 

15.45-16.15 - COFFEE

 

16.15-17.30

Session 4 - A Case of Toxicity and Antidotes

Chair: Professor Michael Eddleston

 

Hypertension management in the era of precision medicine

Professor Sandosh Padmanabhan

Institute of Cardiovascular and Medical Sciences, University of Glasgow

 

Drug-induced liver injury as a model for precision medicine

Dr James Dear

Centre for Cardiovascular Sciences, University of Edinburgh

 

Testing antidotes for poisoning in large animal models

Professor Michael Eddleston,

Centre for Cardiovascular Sciences, University of Edinburgh

 

5.30-7.00pm

Networking and Wine Reception

 

Registration

Please note that there is a nominal £10 registration fee for external registrants 

Registration for this event is essential for all participants,so book your place for the symposium here:

Book a place for Edinburgh Pharmacology 2017

 

Further information

This event aims to provide a networking forum for research workers and clinicians with an interest in therapeutic developments and applications, by describing current projects and activities in the Edinburgh area.

It is supported by the British Pharmacological society ambassador scheme and Edinburgh University.

 

Contact

Prof Mark Evans: Mark.evans@ed.ac.uk

Prof Michael Eddleston: M.eddleston@ed.ac.uk

Dr Anne Leaver: Helen.leaver@nhs.net